Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 71,183 | 91,643 | 96,804 | -12,029 | -63,734 |
| Depreciation Amortization | 3,563 | 2,471 | 1,583 | 815 | 2,907 |
| Accounts receivable | -6,147 | N/A | N/A | N/A | N/A |
| Other Working Capital | -5,387 | -4,794 | 12,231 | -3,422 | -4,383 |
| Other Operating Activity | -139,538 | -147,693 | -147,804 | -3,766 | 9,195 |
| Operating Cash Flow | $-76,326 | $-58,373 | $-37,186 | $-18,402 | $-56,015 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -39,363 | -50,070 | 12,037 | 5,614 | -36,812 |
| PPE Investments | -7,975 | -6,822 | -4,302 | -1,401 | -2,428 |
| Net Acquisitions | 152,366 | N/A | N/A | N/A | N/A |
| Sale Of Investment | N/A | 152,366 | 152,366 | N/A | N/A |
| Investing Cash Flow | $105,028 | $95,474 | $160,101 | $4,213 | $-39,240 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 20,000 |
| Common Stock Issued | 26,077 | 22,463 | 17,300 | 6,799 | 85,628 |
| Other Financing Activity | -37 | -37 | -37 | -31 | -1,489 |
| Financing Cash Flow | $26,040 | $22,426 | $17,263 | $6,768 | $104,139 |
| Beginning Cash Position | 23,695 | 23,695 | 23,695 | 23,695 | 14,811 |
| End Cash Position | 78,437 | 83,222 | 163,873 | 16,274 | 23,695 |
| Net Cash Flow | $54,742 | $59,527 | $140,178 | $-7,421 | $8,884 |
| Free Cash Flow | |||||
| Operating Cash Flow | -76,326 | -58,373 | -37,186 | -18,402 | -56,015 |
| Capital Expenditure | -7,975 | -6,822 | -4,302 | -1,401 | -2,446 |
| Free Cash Flow | -84,301 | -65,195 | -41,488 | -19,803 | -58,461 |